Laborie Medical Technologies completed the acquisition of Urotronic for $600m.

Laborie Medical Technologies, a diagnostic and therapeutic medical technology company, completed the acquisition of Urotronic, a medical device company, for $600m. "We are delighted to welcome the Urotronic team to Laborie, and we look forward to working together in our mission to deliver innovative technologies in the Interventional Urology space that preserve and restore human dignity," Michael Frazzette, Laborie Medical Technologies President and CEO.